RSP-1502

RSP-1502 · Respirion Pharmaceuticals Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RSP-1502, covering 2025-12-29 to 2025-12-29. Get the full timeline:

Most recent: Clinical Trial Update: A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection [Phase 1, Phase 2]

See pricing